Skip navigation
Merrion pharmaceuticals - making medicines better
Skip navigation

Regulatory News

04 March 2011

Appointment of Broker and ESM Adviser

Merrion Pharmaceuticals Plc (ESM: MERR), a publicly listed product development company announces that Davy has been appointed as the Company's broker and ESM Adviser with immediate effect.

Contact Information:

Merrion Pharmaceuticals Plc.  
Jonathan O'Connell, Chief Financial Officer +353 (0)1 642 3300
Davy Corporate Finance  
Ivan Murphy, Director +353 1 679 6363


For further information:


<< Back to Regulatory News